首页> 外文期刊>Frontiers in Cell and Developmental Biology >SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling
【24h】

SH2B3, Transcribed by STAT1, Promotes Glioblastoma Progression Through Transducing IL-6/gp130 Signaling to Activate STAT3 Signaling

机译:SC2B3通过STAT1转录,通过转换IL-6 / GP130信令来激活Stat3信令来促进胶质母细胞瘤进展

获取原文
           

摘要

Abstract Glioblastoma (GBM) is the most common and aggressive brain tumor in adults. Activation of STAT3 commonly occurs in GBM and promotes GBM progression. In this study, we reported that SH2B adaptor protein 3 (SH2B3) is highly expressed in GBM and GBM stem cells and its high expression predicts worse survival of GBM patients. Targeting SH2B3 expression dramatically impairs GBM cell proliferation, migration and GSCs self-renewal in vitro and xenograft tumors growth in vivo. Moreover, we found that STAT1 directly binds to the promoter of SH2B3 and activates its expression in transcriptional level. In addition, SH2B3 facilitates GBM progression via activating STAT3 signaling. Together, our work uncovers a key function for SH2B3 and provides insight into new prognosis marker and therapeutic target in GBM.
机译:摘要胶质母细胞瘤(GBM)是成人中最常见和最富有的脑肿瘤。 STAT3的激活通常发生在GBM中并促进GBM进展。 在这项研究中,我们报道了SH2B适配器蛋白3(SH2B3)在GBM和GBM干细胞中高度表达,其高表达预测GBM患者的更糟存活。 靶向SH2B3表达显着地损害了GBM细胞增殖,迁移和GSCs在体内体外和异种移植肿瘤的生长。 此外,我们发现Stat1直接与SH2B3的启动子结合,并激活其在转录水平中的表达。 另外,SH2B3通过激活STAT3信令促进GBM进展。 我们的工作一起揭示了SH2B3的关键功能,并在GBM中提供了对新预后标志物和治疗目标的洞察力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号